Ativo capital management llc maintains stake in roper technologies, inc. (rop)

Ativo Capital Management LLC continued to hold its position in shares of Roper Technologies, Inc. What is health information management (NYSE:ROP) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. Information about world health organisation The fund owned 9,500 shares of the company’s stock at the end of the fourth quarter. Health information database Ativo Capital Management LLC’s holdings in Roper Technologies were worth $1,739,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company.


Information about health and safety Artisan Partners Limited Partnership boosted its stake in shares of Roper Technologies by 79.2% in the second quarter. Information about health and medicine Artisan Partners Limited Partnership now owns 816,763 shares of the company’s stock valued at $139,307,000 after buying an additional 360,946 shares during the period. Components of health information systems Hamilton Point Investment Advisors LLC boosted its stake in shares of Roper Technologies by 0.4% in the second quarter. Health and medicine information Hamilton Point Investment Advisors LLC now owns 25,988 shares of the company’s stock valued at $4,433,000 after buying an additional 105 shares during the period. Health information exchange organizations Atlantic Trust Group LLC boosted its stake in shares of Roper Technologies by 0.8% in the second quarter. Information about healthy food Atlantic Trust Group LLC now owns 97,417 shares of the company’s stock valued at $16,615,000 after buying an additional 787 shares during the period. Health information news LaFleur & Godfrey LLC boosted its stake in shares of Roper Technologies by 4.8% in the second quarter. Human health information LaFleur & Godfrey LLC now owns 5,855 shares of the company’s stock valued at $999,000 after buying an additional 270 shares during the period. Health information systems degree Finally, Homrich & Berg bought a new stake in shares of Roper Technologies during the second quarter valued at about $546,000. Health information exchange market 97.47% of the stock is currently owned by institutional investors.

Shares of Roper Technologies, Inc. Information about health care ( NYSE:ROP) traded up 0.16% during trading on Friday, reaching $207.14. Information about health is wealth The company had a trading volume of 1,076,865 shares. Information on health and medicine The firm has a 50-day moving average of $188.99 and a 200 day moving average of $180.22. E health information management The firm has a market capitalization of $21.02 billion, a PE ratio of 32.21 and a beta of 0.87. Health information sources Roper Technologies, Inc. Health information exchange standards has a 1-year low of $159.28 and a 1-year high of $207.22.

Roper Technologies (NYSE:ROP) last announced its earnings results on Thursday, February 9th. Health information sites The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.02. Benefits of health information exchange The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.01 billion. Health information systems salary Roper Technologies had a return on equity of 11.97% and a net margin of 17.38%. Health information exchange models The firm’s quarterly revenue was up 6.6% compared to the same quarter last year. What is health information technology During the same quarter in the previous year, the company earned $1.82 earnings per share. Health information systems ppt Analysts expect that Roper Technologies, Inc. Healthcare information exchange will post $9.08 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Monday, January 23rd. Information about health and nutrition Shareholders of record on Monday, January 9th were paid a $0.35 dividend. Useful information about health This is an increase from Roper Technologies’s previous quarterly dividend of $0.30. Health information exchange benefits The ex-dividend date of this dividend was Thursday, January 5th. Benefits of health information systems This represents a $1.40 annualized dividend and a dividend yield of 0.68%. Information about health food Roper Technologies’s payout ratio is 21.77%.

This article was reported by [[site]] and is owned by of [[site]]. B s health information management If you are accessing this article on another publication, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. Online health information The legal version of this article can be viewed at [[permalink]].

Several brokerages have issued reports on ROP. Healthcare information systems RBC Capital Markets reaffirmed a “buy” rating and set a $214.00 target price on shares of Roper Technologies in a research report on Thursday, January 5th. What is health informatics and information management Citigroup Inc. Health care information raised Roper Technologies to an “outperform” rating and set a $225.00 target price on the stock in a research report on Friday, January 6th. Health information exchange vendors J P Morgan Chase & Co raised Roper Technologies from a “neutral” rating to an “overweight” rating and increased their target price for the company from $177.00 to $219.00 in a research report on Friday, January 13th. Health information exchange Oppenheimer Holdings, Inc. Health information systems raised Roper Technologies from a “market perform” rating to an “outperform” rating in a research report on Friday, January 6th. Veterans health information systems and technology architecture Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $175.00 target price on shares of Roper Technologies in a research report on Wednesday, November 2nd. 3m health information systems Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Information of health Roper Technologies currently has a consensus rating of “Buy” and an average target price of $208.78.

In other Roper Technologies news, Director Robert D. Information about healthy living Johnson sold 1,600 shares of the business’s stock in a transaction on Thursday, December 8th. Information about healthy diet The shares were sold at an average price of $183.34, for a total value of $293,344.00. Health information exchange challenges Following the completion of the transaction, the director now owns 8,900 shares in the company, valued at $1,631,726. Free health information The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Health information systems pdf Also, CEO Brian D. Latest health information Jellison sold 108,084 shares of the business’s stock in a transaction on Tuesday, December 13th. Medical health information The stock was sold at an average price of $186.00, for a total transaction of $20,103,624.00. Health information websites Following the completion of the transaction, the chief executive officer now owns 1,375,182 shares of the company’s stock, valued at approximately $255,783,852. What is health care information The disclosure for this sale can be found here. Health information systems management Insiders own 2.50% of the company’s stock.

Roper Technologies, Inc, formerly Roper Industries, Inc, is a technology company. Interoperability of health information systems The Company operates businesses that design and develop software and engineered products and solutions for a range of end markets, including healthcare, transportation, food, energy, water, education and academic research.

Want to see what other hedge funds are holding ROP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roper Technologies, Inc. What is health information exchange (NYSE:ROP).

Get Analysts’ Upgrades and Downgrades Daily – Enter your email address below to receive a concise daily summary of analysts’ upgrades, downgrades and new coverage with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *